Redmile Group, LLC: insider trades.
Redmile Group, LLC reported 5 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 2 open-market purchases ($10.2M) and 0 sales, across 2 companies.
- Transactions
- 5
- Purchases (P)
- 2
- Sales (S)
- 0
- Companies
- 2
- Name as filed
- Redmile Group, LLC
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Attovia Therapeutics, Inc. (ATTO) | TenPercentOwner | 3 |
| Atara Biotherapeutics, Inc. (ATRA) | Director | 2 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-06 | Attovia Therapeutics, Inc. | P | 200,000 | $17 | 982,854 | Form 4 |
| 2026-08-06 | Attovia Therapeutics, Inc. | C | 782,854 | — | 782,854 | Form 4 |
| 2026-08-06 | Attovia Therapeutics, Inc. | P | 400,000 | $17 | 1,182,854 | Form 4 |
| 2026-07-22 | Atara Biotherapeutics, Inc. | F | 60 | — | 636,852 | Form 4 |
| 2026-07-22 | Atara Biotherapeutics, Inc. | M | 195,211 | — | 636,912 | Form 4 |
Questions
What stock did Redmile Group, LLC buy or sell?
Redmile Group, LLC reported 5 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 2 open-market purchases ($10.2M) and 0 sales, across 2 companies.
Is Redmile Group, LLC the same person as other filers with this name?
This page covers SEC CIK 1425738 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/redmile-group-llc-1425738.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.